NR3C1 and substance withdrawal syndrome: DEGs were also involved in the pathway in glucocorticoid receptor regulatory network, and diseases such as sleep disorders, Clostridium difficile, glucocorticoid receptor deficiency, substance withdrawal syndrome, and stress, psychological (Figure 5C, Supplementary Table S2).